PT99513A - Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica - Google Patents
Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermicaInfo
- Publication number
- PT99513A PT99513A PT99513A PT9951391A PT99513A PT 99513 A PT99513 A PT 99513A PT 99513 A PT99513 A PT 99513A PT 9951391 A PT9951391 A PT 9951391A PT 99513 A PT99513 A PT 99513A
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- profarmacas
- transdermic
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003665A SE9003665D0 (sv) | 1990-11-16 | 1990-11-16 | Morphine prodrugs |
Publications (2)
Publication Number | Publication Date |
---|---|
PT99513A true PT99513A (pt) | 1992-09-30 |
PT99513B PT99513B (pt) | 1999-04-30 |
Family
ID=20380936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99513A PT99513B (pt) | 1990-11-16 | 1991-11-14 | Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica |
Country Status (18)
Country | Link |
---|---|
US (1) | US5908846A (pt) |
EP (1) | EP0557385B1 (pt) |
JP (1) | JP3493434B2 (pt) |
AT (1) | ATE168560T1 (pt) |
AU (1) | AU655612B2 (pt) |
CA (1) | CA2095223C (pt) |
DE (1) | DE69129861T2 (pt) |
DK (1) | DK0557385T3 (pt) |
ES (1) | ES2121793T3 (pt) |
FI (1) | FI932212A0 (pt) |
IE (1) | IE913682A1 (pt) |
IL (1) | IL99905A (pt) |
NO (1) | NO931766L (pt) |
NZ (1) | NZ240349A (pt) |
PT (1) | PT99513B (pt) |
SE (1) | SE9003665D0 (pt) |
WO (1) | WO1992008459A1 (pt) |
ZA (1) | ZA918512B (pt) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
DE4403709A1 (de) * | 1994-02-07 | 1995-08-10 | Lohmann Therapie Syst Lts | Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid |
JPH07267862A (ja) * | 1994-03-29 | 1995-10-17 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
DE19508664C2 (de) * | 1995-03-14 | 2001-08-23 | Christian Mignat | Verwendung von Morphin-3-estern, Morphin-3-ester als solche und Verfahren zu deren Herstellung |
AU5108596A (en) * | 1995-03-14 | 1996-10-02 | Mundipharma Gmbh | Morphine-3-esters |
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
DE19602964A1 (de) * | 1995-12-20 | 1997-07-31 | Nycomed Arzneimittel Gmbh | Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung |
DE19923551A1 (de) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US20020013331A1 (en) | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
CN100518827C (zh) | 2000-10-30 | 2009-07-29 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
US6569449B1 (en) * | 2000-11-13 | 2003-05-27 | University Of Kentucky Research Foundation | Transdermal delivery of opioid antagonist prodrugs |
KR100612398B1 (ko) * | 2000-11-14 | 2006-08-16 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 포스페이트 유도체의 착체 |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
KR20040014544A (ko) * | 2001-06-05 | 2004-02-14 | 컨트롤 딜리버리 시스템즈 인코포레이티드 | 서방 진통제 화합물 |
AU2002317053B2 (en) * | 2001-07-27 | 2004-08-05 | Vital Health Sciences Pty Ltd | Dermal therapy using phosphate derivatives of electron transfer agents |
WO2003049774A1 (en) * | 2001-12-13 | 2003-06-19 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
DE60329515D1 (de) * | 2002-10-25 | 2009-11-12 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
WO2004043396A2 (en) * | 2002-11-09 | 2004-05-27 | Nobex Corporation | Modified carbamate-containing prodrugs and methods of synthesizing same |
US20060241085A1 (en) * | 2003-01-17 | 2006-10-26 | West Simon M | Compounds having anti-proliferative properties |
AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
EP1638492B1 (en) * | 2003-07-25 | 2008-01-02 | Euro-Celtique S.A. | Preoperative treatment of post operative pain |
ATE451374T1 (de) | 2004-02-06 | 2009-12-15 | Euro Celtique Sa | Verfahren zur herstellung 3-o-geschützter morphinone und 3-o-geschützter morphinon-dienol- carboxylate |
RS50963B (sr) | 2004-02-23 | 2010-10-31 | Euro-Celtique S.A. | Opioidni transdermalni preparat otporan na zloupotrebu |
EP1720551B9 (en) | 2004-03-03 | 2011-09-21 | Vital Health Sciences Pty Ltd. | Alkaloid formulations |
EP1893159B1 (en) | 2005-06-17 | 2015-09-30 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents |
EP1973547A1 (en) * | 2005-12-23 | 2008-10-01 | Vital Health Sciences Pty Ltd. | Compounds having cytokine modulating properties |
CN101621999B (zh) | 2007-03-02 | 2012-09-26 | 帝化制药株式会社 | 经皮吸收医药组合物、医药组合物储存单元以及利用了该储存单元的经皮吸收制剂 |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
US8354116B2 (en) * | 2007-06-18 | 2013-01-15 | Biochemics, Inc. | Bifunctional synthetic molecules |
US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
WO2009158667A2 (en) * | 2008-06-27 | 2009-12-30 | Comgenrx, Inc. | Povidone compositions for wound healing |
US10849981B2 (en) | 2009-07-02 | 2020-12-01 | KemPham, Inc. | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
CA2765836C (en) | 2009-07-02 | 2014-10-07 | Kempharm, Inc. | Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof |
UA102916C2 (uk) * | 2009-07-02 | 2013-08-27 | Кемфарм, Інк. | Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань |
EP2531047A4 (en) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE |
ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
US11607407B2 (en) | 2010-04-13 | 2023-03-21 | Relmada Therapeutics, Inc. | Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use |
TWI590821B (zh) | 2011-01-18 | 2017-07-11 | 輝瑞有限公司 | 固體分子分散液 |
WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
RU2683317C2 (ru) | 2014-11-25 | 2019-03-28 | Кемфарм, Инк. | Конъюгаты оксикодона с бензойной кислотой, производными бензойной кислоты и гетероарилкарбоновой кислотой |
CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
MX2019006845A (es) | 2016-12-21 | 2019-10-15 | Avecho Biotechnology Ltd | Proceso. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
US4908389A (en) * | 1986-08-27 | 1990-03-13 | Warner-Lambert Company | Penetration enhancement system |
US4940586A (en) * | 1987-02-26 | 1990-07-10 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4879297A (en) * | 1987-06-01 | 1989-11-07 | Warner-Lambert Company | Fatty acids and their small chain esters as penetration enhancers in aqueous systems |
US4891377A (en) * | 1988-12-02 | 1990-01-02 | Board Of Regents Acting For And On Behalf Of University Of Michigan | Transdermal delivery of the narcotic analgesics etorphine and analogs |
WO1991015241A1 (en) * | 1990-03-30 | 1991-10-17 | Yasunori Morimoto | Percutaneously absorbable composition of narcotic and nonnarcotic analgesics |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
-
1990
- 1990-11-16 SE SE9003665A patent/SE9003665D0/xx unknown
-
1991
- 1991-10-21 IE IE368291A patent/IE913682A1/en not_active IP Right Cessation
- 1991-10-25 ZA ZA918512A patent/ZA918512B/xx unknown
- 1991-10-25 NZ NZ240349A patent/NZ240349A/en not_active IP Right Cessation
- 1991-10-30 IL IL9990591A patent/IL99905A/en not_active IP Right Cessation
- 1991-11-11 AT AT91920399T patent/ATE168560T1/de not_active IP Right Cessation
- 1991-11-11 JP JP50056892A patent/JP3493434B2/ja not_active Expired - Fee Related
- 1991-11-11 EP EP91920399A patent/EP0557385B1/en not_active Expired - Lifetime
- 1991-11-11 CA CA002095223A patent/CA2095223C/en not_active Expired - Fee Related
- 1991-11-11 DE DE69129861T patent/DE69129861T2/de not_active Expired - Fee Related
- 1991-11-11 ES ES91920399T patent/ES2121793T3/es not_active Expired - Lifetime
- 1991-11-11 DK DK91920399T patent/DK0557385T3/da active
- 1991-11-11 AU AU89381/91A patent/AU655612B2/en not_active Ceased
- 1991-11-11 WO PCT/SE1991/000760 patent/WO1992008459A1/en active IP Right Grant
- 1991-11-11 US US08/050,336 patent/US5908846A/en not_active Expired - Fee Related
- 1991-11-14 PT PT99513A patent/PT99513B/pt not_active IP Right Cessation
-
1993
- 1993-05-14 NO NO93931766A patent/NO931766L/no unknown
- 1993-05-14 FI FI932212A patent/FI932212A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
US5908846A (en) | 1999-06-01 |
DK0557385T3 (da) | 1999-04-26 |
FI932212A (fi) | 1993-05-14 |
DE69129861T2 (de) | 1999-04-01 |
ES2121793T3 (es) | 1998-12-16 |
WO1992008459A1 (en) | 1992-05-29 |
AU655612B2 (en) | 1995-01-05 |
DE69129861D1 (de) | 1998-08-27 |
JPH06502422A (ja) | 1994-03-17 |
CA2095223A1 (en) | 1992-05-17 |
NO931766D0 (no) | 1993-05-14 |
IE913682A1 (en) | 1992-05-20 |
IL99905A0 (en) | 1992-08-18 |
PT99513B (pt) | 1999-04-30 |
NO931766L (no) | 1993-05-14 |
EP0557385A1 (en) | 1993-09-01 |
JP3493434B2 (ja) | 2004-02-03 |
SE9003665D0 (sv) | 1990-11-16 |
IL99905A (en) | 1995-06-29 |
NZ240349A (en) | 1993-07-27 |
EP0557385B1 (en) | 1998-07-22 |
FI932212A0 (fi) | 1993-05-14 |
AU8938191A (en) | 1992-06-11 |
CA2095223C (en) | 2002-12-17 |
ZA918512B (en) | 1992-08-26 |
ATE168560T1 (de) | 1998-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT99513A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica | |
DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
BR9406779A (pt) | Complexos de inclusão de multicomponentes altamente solúveis contendo uma droga de tipo básico um ácido e uma ciclodextrina | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
FI962550A (fi) | Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa | |
PT90308A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa | |
DK0561846T3 (da) | 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning | |
ATE246515T1 (de) | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac | |
SE9303853L (sv) | Användning av en inositoltrisfosfatester för beredning av läkemedel | |
ATE234096T1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
EP0348664A3 (en) | Pharmaceutical compositions containing monoacetoacetins for treating tumours | |
ES2122005T3 (es) | Medicamento que contiene (-)-metrifonato. | |
EP0335446A3 (en) | Agents for treating neoplasms | |
ES2072005T3 (es) | Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920525 |
|
FG3A | Patent granted, date of granting |
Effective date: 19990126 |
|
MM3A | Annulment or lapse |
Effective date: 20060726 |